[ET Net News Agency, 26 January 2024] LEPU BIO-B (02157) rose 13.4% to HK$3.3, breaking
above the 10-D SMA of HK$3.118.
It hits an intra-day high of HK$3.35, and an intra-day low of HK$2.86. The total shares
traded was 820,000, with a value of HK$2.53m. The active buy/sell ratio is 76:24, with net
buying turnover of HK$1.14m. CMB INT'L SEC accounts for greatest net responsive buying
turnover of HK$99,025, with volume weighted average price of HK$3.047. CHINA INNOVATION
MARKET SER accounts for greatest net responsive selling turnover of HK$171,227, with
volume weighted average price of HK$3.076.

Basic Information
=================

-----------------------------------
Nominal 3.300 % Chg +13.40%
High 3.350 Low 2.860
Shares Tr 820,000 Turnover 2.53m
10-D SMA 3.118 %H.V 89.402
20-D SMA 3.500 VWAP 3.083
50-D SMA 3.580 RSI14 47.259
-----------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 76:24, with net buying
turnover of HK$1.14m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
LEPU BIO-B (02157) 3.30 +13.40
HUTCHMED (00013) 22.50 +4.65
FRONTAGE (01521) 1.99 -2.93
GENSCRIPT BIO (01548) 16.40 -0.73
INNOVENT BIO (01801) 35.60 -1.11
WUXI BIO (02269) 31.65 +5.50
BEIGENE (06160) 99.95 +3.41
SCICLONE PHARMA (06600) 11.66 +6.00
AKESO (09926) 43.90 -0.45
REMEGEN (09995) 21.65 +3.10
-----------------------------------------------
(ed)